Warning Letters to Telehealth providers marketing GLP-1 compounded On March 3rd, FDA sent multiple sets of warnings to 30 Telehealth companies offering GLP-1s on their websites warning them to refrain from improperly using a brand when they are not the compounder or claiming equivalency to FDA approved drugs
Some of the most common GLP-1 side effects include: nausea vomiting diarrhea constipation abdominal discomfort
Patient Perspective: Several of my South Asian patients have found success with Saxenda because the daily dosing gives them a sense of control and consistency with their weight management routine
Most users report that gains in body composition and metabolic markers hold partially during the off period, particularly if diet and training remain consistent
A recent article has suggested that appetite suppression may make it hard for some athletes to eat enough for all of their caloric and nutritional needs, so special care should be taken by athletes on GLP-1s
Low-dose oral minoxidil (LDOM) has emerged as a viable treatment for many adolescents and adults experiencing hair loss among the available therapeutic options
